Results 71 to 80 of about 737 (195)
Methylprednisolone aceponate (MPA)* — a new therapeutic for eczema: A pharmacological overview
Journal of Dermatological Treatment, 1992 Advantan* is a new potent corticoid preparation that has been specially developed for the local treatment of eczematous dermatoses. The active ingredient of Advantan is methylprednisolone aceponate (MPA), a nonhalogenated corticoid diester. Advantan has been developed in three different formulations (cream, ointment, fatty ointment).
R-P Zaumseil +3 more
openaire +1 more source
A case of miliaria profunda after excessive sweating during a summer vacation
JEADV Clinical Practice, Volume 3, Issue 5, Page 1602-1605, December 2024.Capsule Summary A 34‐year‐old healthy man presented with a 6‐week history of anhidrosis and heat intolerance after a trip to Mallorca. He experienced nonpruritic, transient papular lesions during overheating, accompanied by dizziness and palpitations.
Ariana Palacio +5 more
wiley +1 more source
Safety aspects of topical methylprednisolone aceponate (MPA) treatment
Journal of Dermatological Treatment, 1992 Many side effects, both local or systemic, may result from topical steroid therapy, especially after long-lasting treatment with potent corticosteroids. Of particular importance are the depression of the hypothalamic pituitary adrenal axis and the local side-effects from topical application consisting mainly of skin atrophy.
openaire +1 more source
Australasian Journal of Dermatology, Volume 65, Issue 5, Page 467-471, August 2024.Abstract Dermoscopy can be an important help for the diagnosis of skin cancers and inflammatory cutaneous diseases. The list of the dermoscopic features reported in granuloma faciale is wide and includes vascular and non‐vascular features. We report here three cases of diffuse flat facial and extrafacial granuloma faciale that exhibited elongated ...
Francesco Savoia +9 more
wiley +1 more source
Contact Dermatitis, Volume 91, Issue 2, Page 146-151, August 2024.Symmetrical drug‐related intertriginous and flexural exanthema (SDRIFE) is a rare presentation of drug‐induced type IV hypersensitivity reactions. This case series examines four cases of SDRIFE following systemic prednisolone therapy and evaluates existing corticosteroid (CS) classification systems.
Julian Steininger +4 more
wiley +1 more source
Clinical experience with methylprednisolone aceponate (MPA) in eczema
Journal of Dermatological Treatment, 1992 Effectiveness and side-effects of the new topical halogenfree corticosteroid methylprednisolone aceponate (MPA) (0.1% in commercial o/w or w/o emulsions) were tested in six multicentre controlled double-blind studies, using betamethasone valerate (BMV) as control (0.1% in o/w emulsion); a total of 1723 patients with various kinds of eczema were ...
openaire +1 more source
Adult genital psoriasis: An updated review for clinicians
Australasian Journal of Dermatology, Volume 65, Issue 3, Page e1-e12, May 2024.Abstract Genital psoriasis is a chronic inflammatory skin condition that has been reported in up to 63% of patients with psoriasis on other parts of their skin. It has a profound impact on quality of life and sexual function which is often overlooked by current severity scores.
Michelle Wu, Gayle Fischer
wiley +1 more source
Establishment of framework for classification/categorisation and labelling of medicinal drugs and driving [PDF]
, 2011 The establishment of criteria for a European categorisation will have to serve most of the needs of all parties involved: health professionals, drug regulatory agencies, drug manufacturers and patients. Clear warnings and symbols are needed so patients
Fierro Lorenzo, María Inmaculada +2 more
core +1 more source
Vulvovaginal lichen planus mimicking desquamative inflammatory vulvovaginitis: A case series
Australasian Journal of Dermatology, Volume 65, Issue 7, Page e203-e207, November 2024.
Marlene Wijaya +2 more
wiley +1 more source
Improvement of Fox-Fordyce disease with botulinum toxin type A [PDF]
Fox-Fordyce disease is a rare, chronic, pruritic papular eruption affecting apocrine gland-rich areas, predominantly in premenopausal women. There is no standardized treatment for Fox-Fordyce disease and various therapies have yielded mixed results ...
Brazao, Claudia +6 more
core +1 more source